Skip to main content
TipRanks
Go Ultimate75% OFF

Parenteral Drugs (India) Limited (PDPL) Stock Statistics & Valuation Metrics

0 Followers

Total Valuation

Parenteral Drugs (India) Limited has a market cap or net worth of $101.08M. The enterprise value is $1173.07T.

Market Cap
$101.08M
Enterprise Value
$1173.07T

Share Statistics

Parenteral Drugs (India) Limited has 29,816,300 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding
29,816,300
Owned by Insiders
―
Owned by Institutions
―

Financial Efficiency

Parenteral Drugs (India) Limited’s return on equity (ROE) is 0.09 and return on invested capital (ROIC) is <0.01%.

Return on Equity (ROE)
0.09
Return on Assets (ROA)
-0.16
Return on Invested Capital (ROIC)
<0.01%
Return on Capital Employed (ROCE)
0.00
Revenue Per Employee
93.47K
Profits Per Employee
-840.06K
Employee Count
909
Asset Turnover
0.02
Inventory Turnover
5.32

Valuation Ratios

The current PE Ratio of Parenteral Drugs (India) Limited is -0.11. Parenteral Drugs (India) Limited’s PEG ratio is -0.00.

PE Ratio
-0.11
PS Ratio
1.19
PB Ratio
-0.01
Price to FCF
-20.94
Price to Operating Cash Flow
-17.91
PEG Ratio
-0.00

Income Statement

In the last 12 months, Parenteral Drugs (India) Limited had revenue of 84.96M and earned -763.62M in profits. Earnings per share was -25.61.

Revenue
84.96M
Gross Profit
30.31M
Operating Income
-117.56K
Pretax Income
-1.09M
Net Income
-763.62M
EBITDA
372.69M
Earnings Per Share (EPS)
-25.61

Cash Flow

In the last 12 months, operating cash flow was 0 and capital expenditures 0, giving a free cash flow of 0 billion.

Operating Cash Flow
0
Free Cash Flow
0
Free Cash Flow per Share
-0.16

Dividends & Yields

Parenteral Drugs (India) Limited pays an annual dividend of $1.13, resulting in a dividend yield of ―

Dividend Per Share
$1.13
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
-4.78%
Earnings Yield
-883.10%

Important Dates

Parenteral Drugs (India) Limited upcoming earnings date is ―, Before Open (Confirmed).

Last Earnings Date
―
Next Earnings Date
―
Ex-Dividend Date
Sep 13, 2010

Financial Position

Parenteral Drugs (India) Limited as a current ratio of 0.06, with Debt / Equity ratio of -13.01%

Current Ratio
0.06
Quick Ratio
0.06
Debt to Market Cap
9.99
Net Debt to EBITDA
2.88
Interest Coverage Ratio
-0.00

Taxes

In the past 12 months, Parenteral Drugs (India) Limited has paid -327.64K in taxes.

Income Tax
-327.64K
Effective Tax Rate
0.30

Enterprise Valuation

Parenteral Drugs (India) Limited EV to EBITDA ratio is 3.15, with an EV/FCF ratio of -243.02.

EV to Sales
13.81
EV to EBITDA
3.15
EV to Free Cash Flow
-243.02
EV to Operating Cash Flow
-243.02

Balance Sheet

Parenteral Drugs (India) Limited has $1,000.00 in cash and marketable securities with $1.07B in debt, giving a net cash position of -$1.07B billion.

Cash & Marketable Securities
$1,000.00
Total Debt
$1.07B
Net Cash
-$1.07B
Net Cash Per Share
-$35.95
Tangible Book Value Per Share
-$276.33

Margins

Gross margin is 35.67%, with operating margin of -0.14%, and net profit margin of -898.77%.

Gross Margin
35.67%
Operating Margin
-0.14%
Pretax Margin
-1.28%
Net Profit Margin
-898.77%
EBITDA Margin
438.65%
EBIT Margin
-33.89%